Common GLP-1 agonists include: Semaglutide (Ozempic, Wegovy) Liraglutide (Victoza, Saxenda) Dulaglutide (Trulicity) Tirzepatide (Zepbound) While initially used for diabetes management, studies showed that GLP-1 agonists also contribute significantly to weight loss, leading to their approval for obesity treatment as well
2023 Aug;402(10401):52944
STEP 5: the two-year study Duration matters for understanding the full timeline
Behavioural techniques proven effective in weight maintenance include: Daily self-weighing to detect early regain (weight fluctuations of 12 kg are normal) Identifying and managing emotional or stress-related eating triggers Maintaining social support through weight management groups or healthcare contacts Planning for high-risk situations (social events, holidays, stressful periods) Sleep and stress management also influence weight regulation
It might be neutral
Tien T, Zhang J, Muto T, Kim D, Sarthy VP, Roy S